Adherence to self-administered biologic disease-modifying antirheumatic drugs across health-system specialty pharmacies

by Canfield, S., Carter, J., Choi, L., Cowgill, N., Declercq, J., Dura, J., Gazda, N.P, Gerzenshtein, L., Kehasse, A., Lach, M., Lee, J., Lewis, K., Lounsbery, B., Mccarthy, K., Ortega, M., Shah, R., Sokos, L., Stutsky, M., Thomas, K.C, Thomas, T.T, Wise, K., Young, J., Zuckerman, A.D
Published 2021

Adherence to oral oncolytics filled through an internal health-system specialty pharmacy compared with external specialty pharmacies

by Academia, E.C, Jia, L.Y, Lee, J., Mejías-De Jesús, C.M, Patel, C., Stevens, J.S, Yankama, T.
Published 2021

Prevalence of drug-drug interactions with pangenotypic direct-acting antivirals for hepatitis C and real-world care management in the United States: A retrospective observational s...

by Afdhal, N.H, Curry, M.P, Flamm, S.L, Milligan, S., Tsai, N., Wick, N., Younossi, Z.
Published 2021

Characterizing patient assistance program use and patient responsiveness to specialty drug price for multiple sclerosis in a mid-size integrated health system

by Barthold, D., Brouwer, E., Hansen, R., Yeung, K.
Published 2021

Meeting the affordability challenges posed by orphan drugs: A survey of payers, providers, and employers

by Gopalan, A., Ladikos, N., Lopata, E., Richardson, T., Terrone, C.
Published 2021

A framework for graduate and postgraduate specialty pharmacy training

by Cesarz, J.L, Friestrom, E.D, Mott, D.A
Published 2021

Development, implementation, and evaluation of a health outcomes and research program at an integrated health-system specialty pharmacy

by Jolly, J.A, Kelley, T.N, Peter, M.E, Shah, N.B, Zuckerman, A.D
Published 2021

Poster Abstracts - Academy of Managed Care Pharmacy Virtual 2021

Published 2021

Effect of clinical pharmacist interventions on cost in an integrated health system specialty pharmacy

by Dura, J., Geyer, K., Lam, S.W, Lankford, C., Naelitz, B., Tran, A., Willner, M.
Published 2021

Applicability of a new specialty pharmacy-reported measure describing completion of therapy for hepatitis C

by Bolduc, C., Gelinas, A., Levesque, E., McCall, K., Stickney, K.
Published 2021

Inclusion in limited distribution drug network reduces time to dalfampridine access in patients with multiple sclerosis at a health-system specialty pharmacy

by Banks, A., Choi, L., DeClercq, J., Givens, G., Markley, B., Peter, M.E, Zuckerman, A.D
Published 2021